knowledge -WSS

knowledge

author：Wikipedia 2025-10-01 01:51:11 - browse：1428

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Supreme Court strikes down use of affirmative action

WSS

Heart attack and stroke risk calculators need revising

Dairy farmers resist CDC push for PPE against bird flu virus

Moonlake's readout produced a cash windfall. Risks remain

Apple Watch's A

Sanofi strikes deal with Novavax, boosting the vaccine maker

Apple Watch's A

hotspot

knowledge

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Study: People of West African ancestry at greater risk of cardiac amyloidosis

How to save PrEP access — and even expand it

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Drug repurposing or repositioning? The language matters

Study: Adult vaccinations pay for themselves in societal benefits

ChatGPT in medicine: STAT answers readers' burning questions

First recipient of genetically engineered pig kidney has died

BioMarin wins approval for gene therapy to treat hemophilia A

After gene therapy, two congenitally deaf children hear for the first time

explore

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Apple Watch's A

As demand for Covid shots wanes, Moderna seeks its next success

After gene therapy, two congenitally deaf children hear for the first time

Software glitch causes Tandem insulin pump to shutdown, FDA warns

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Wikipedia

hotspot

hotspot

explore